Loading…
Medical Affairs Strategic Summit 2021 has ended

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Monday, September 13
 

9:00am EDT

Promotional Review Morning Workshop - Mock Product Group Activity
In this interactive discussion, attendees will be broken up into small groups which will each be given a unique mock-product and market landscape. These mini committees will be assigned with the task of developing a series of communications through a marketing, medical, regulatory, and legal lens. Attendees will then all come back together, and each group will present their collateral for review and feedback.


Speakers
avatar for Howard Dorfman

Howard Dorfman

Distinguished Visiting Practitioner and Adjunct Professor, Seton Hall University School of Law
Howard L. Dorfman is an Adjunct Professor and Distinguished Practitioner in Residence at Seton Hall Law School where he has taught courses on FDA Regulations, Health Law and Healthcare Compliance and is Founder of H.L. Dorfman Pharmaceutical Consulting, LLC, which provides compliance... Read More →


Monday September 13, 2021 9:00am - 12:00pm EDT

12:00pm EDT

Workshop Luncheon
Monday September 13, 2021 12:00pm - 1:00pm EDT

1:00pm EDT

Medical Affairs Afternoon Workshop – Am I doing this right? An Industry Workshop on Compliance
The Pharmaceutical Industry has an ethical obligation to provide fair-balanced scientific information and education about their products, not only to the health care community but to the patients receiving the treatments. PhRMA guidelines provide the guardrails that ensure all are operating with integrity and upholding high ethical standards. There are company variations regarding compliance guidelines, however, at their core, compliant methodologies and guidances are consistent across the pharmaceutical industry.

This workshop will provide discussions on Medical Science Liaison, Manager, Headquarter, and Commercial interactions; and will include a review of the guidelines across the product lifecycle. Understanding compliance is not straightforward, but knowing the basics will provide confidence in performing daily activities. During an interactive discussion, you will have the opportunity to discuss scenarios in a safe space with industry peers and learn to be more comfortable when talking about and asking questions about compliance.

Speakers
avatar for Jaclyn Quilantan,

Jaclyn Quilantan,

Medical Science Liaison, Kala Pharmaceuticals
Jaclyn is a Medical Science Liaison at Kala Pharmaceuticals. She completed her B.S. in Biology from St. Mary’s University in San Antonio, and her Ph.D. in Biomedical Sciences from the University of North Texas Health Science Center in Fort Worth. After completing her Ph.D. she assumed... Read More →
avatar for Howard Dorfman

Howard Dorfman

Distinguished Visiting Practitioner and Adjunct Professor, Seton Hall University School of Law
Howard L. Dorfman is an Adjunct Professor and Distinguished Practitioner in Residence at Seton Hall Law School where he has taught courses on FDA Regulations, Health Law and Healthcare Compliance and is Founder of H.L. Dorfman Pharmaceutical Consulting, LLC, which provides compliance... Read More →


Monday September 13, 2021 1:00pm - 4:00pm EDT
 
Tuesday, September 14
 

7:30am EDT

Networking Breakfast and Registration
Tuesday September 14, 2021 7:30am - 8:30am EDT

8:30am EDT

Chairperson’s Opening Remarks
Speakers
avatar for Mandeep Kaur, MD, MS

Mandeep Kaur, MD, MS

Vice President and Global Head of Medical, Arena Pharmaceuticals, Inc
Mandeep Kaur is a physician scientist and currently the Vice President, Head of Global Medical at Arena Pharmaceuticals. An experienced leader with over 15 years of research and development experience in both drug and device development. She also has extensive experience in clinical... Read More →


Tuesday September 14, 2021 8:30am - 8:45am EDT

8:45am EDT

Keynote: How Medical Affairs Delivers Value Through Content Leadership
  • Understand the evolving ecosystem of healthcare and the important role of evidence
  • Discuss how Medical Affairs is uniquely positioned to shape and advance clinical practice

Speakers
avatar for Jing L. Marantz, MD PhD

Jing L. Marantz, MD PhD

Senior Vice President, Head of Medical Affairs, Acceleron Pharma
Jing L. Marantz, MD PhD, is SVP, Head of Medical Affairs at Acceleron Pharma and a board member at Krystal Biotech. Prior to Acceleron, Dr. Marantz has held leadership positions at Alnylam, Alexion, Biogen, ARIAD, and Millennium Pharmaceuticals across development, medical affairs... Read More →


Tuesday September 14, 2021 8:45am - 9:15am EDT

9:15am EDT

Shape How Virtual Engagement is Used to Navigate the World Ahead with Top Medical Affairs Trends
  • Explore best tactics to implement into your strategy in order to gain a competitive advantage
  • Discuss how virtual engagement improves internal and external stakeholder alignment
  • Share real-world success stories when leveraging compliant virtual technology

Speakers
avatar for Peter Gannon

Peter Gannon

SVP, Business Partnerships, Within3, Inc.
With more than 19 years diversified experience in the life sciences vertical, Peter has been involved in digital pharmaceutical communications since 1996. His leadership in strategic planning, revenue generation, and business partnering has established a strong and diverse client-base... Read More →


Tuesday September 14, 2021 9:15am - 9:45am EDT

9:45am EDT

Networking Break
Tuesday September 14, 2021 9:45am - 10:15am EDT

10:15am EDT

Panel: Emerging from the Pandemic: Finding a Proper Balance in Virtual vs. Hybrid Engagement
  • What does medical affairs look like in this new environment?
  • How to build your medical affairs strategy and build effective teams in this new environment
  • What does collaboration with commercial look like now?
  • How to maximize medical engagements in a hybrid conference setting?

Moderators
avatar for Kirk Shepard, MD

Kirk Shepard, MD

Chief Medical Officer & SVP, Head of Global Medical Affairs OBG, Eisai, Inc.
Dr. Kirk Shepard is a board-certified medical oncologist and hematologist physician. He is currently CMO and Senior Vice President, Head of Global Medical Affairs Oncology at Eisai Inc. Pharmaceutical Company. Dr. Shepard’s experience in multiple therapeutic areas includes diverse... Read More →

Speakers
avatar for Kent Christopherson, PhD

Kent Christopherson, PhD

Senior Director, Medical Affairs - Americas, Orchard Therapeutics
Dr. Christopherson is the Senior Director, Medical Affairs – Americas at Orchard Therapeutics, a biotech company dedicated to unlocking the curative potential of hematopoietic stem cell – gene therapy for the benefit of individuals, families, and society. He is an accomplished... Read More →
avatar for Harmony P. Garges, MD, MPH

Harmony P. Garges, MD, MPH

Senior Vice President, Chief Medical Officer, ViiV Healthcare
Dr. Harmony P. Garges is the Chief Medical Officer at Viiv Healthcare, the only pharmaceutical company dedicated to HIV, and leads the Global Medical team. She is a physician with expertise in paediatric infectious diseases and spent nearly 20 years taking care of children living... Read More →
avatar for Paul J. Rowe, MD, ATSF

Paul J. Rowe, MD, ATSF

Vice President, Head of Global Medical Immunology, Sanofi-Genzyme
Dr. Rowe has well over a decade of research experience spanning from pre-clinical to late phase innovative medical therapy development programs, primarily in respiratory (and cardiovascular) medicine within the pharma industry. He has been directly responsible for medical strategy... Read More →
avatar for Camille Hertzka

Camille Hertzka

Vice President, Head of Medical Affairs, US Oncology, AstraZeneca
As the Medical Head of US Oncology, Camille Hertzka leads the teams responsible for the development and delivery of the medical strategy across AstraZeneca’s oncology portfolio. She is a leading voice both within Medical Affairs and the company for inclusion and diversity efforts... Read More →


Tuesday September 14, 2021 10:15am - 11:00am EDT

11:00am EDT

Modern Medical Grantmaking - Leveraging Technology to Reduce Complexity and Increase Transparency
  • How processing and tracking medical grants can be greatly simplified, while maintaining flexibility
  • Why fragmented solutions don't work, and how to coordinate efficiently
  • How to reduce friction across the grant lifecycle with automation
  • What true visibility and transparency can look like throughout the process

Speakers
avatar for Daniel Thomas

Daniel Thomas

Solution Architect, CyberGrants
Dan is responsible for providing guidance to both new and existing customers on industry trends and strategies. Dan has developed and deployed numerous software solutions for Research Grants, Medical Education and Managed Access designed to automate manual processes as well as ensure... Read More →


Tuesday September 14, 2021 11:00am - 11:30am EDT

11:30am EDT

Conference Chair Introduces Tracks
Speakers
avatar for Mandeep Kaur, MD, MS

Mandeep Kaur, MD, MS

Vice President and Global Head of Medical, Arena Pharmaceuticals, Inc
Mandeep Kaur is a physician scientist and currently the Vice President, Head of Global Medical at Arena Pharmaceuticals. An experienced leader with over 15 years of research and development experience in both drug and device development. She also has extensive experience in clinical... Read More →


Tuesday September 14, 2021 11:30am - 11:45am EDT

11:45am EDT

Networking Luncheon
Tuesday September 14, 2021 11:45am - 1:00pm EDT

1:00pm EDT

Investigator-Initiated Trials Track Chair - Opening Remarks
Speakers
avatar for Bryan Bischel

Bryan Bischel

Medical Director, Hepatology, Mallinckrodt Pharmaceuticals
Bryan Bischel is an accomplished senior Medical Affairs professional with more than 20 years of progressively responsible medical affairs experience.  He is a strategic thinker skilled at developing and implementing programs to support medical affairs and corporate level objectives... Read More →


Tuesday September 14, 2021 1:00pm - 1:15pm EDT

1:00pm EDT

Medical Affairs Strategy Track Chair - Opening Remarks
Speakers
avatar for Mark Wildgust, PhD

Mark Wildgust, PhD

Vice President, Global Medical Affairs Oncology, Janssen Pharmaceutical Companies of Johnson & Johnson
Mark Wildgust has spent more than 20 years in the pharmaceutical industry working primarily in oncology, hematology and virology. He completed his undergraduate degree in Biological Sciences at the University of Plymouth, UK, and his PhD in Trace Metal Toxicology at the University... Read More →


Tuesday September 14, 2021 1:00pm - 1:15pm EDT

1:00pm EDT

MSL Best Practices Track Chair - Opening Remarks
Speakers
avatar for Ravi Tayi, MD, MPH

Ravi Tayi, MD, MPH

Chief Medical Officer & Head of Global Medical Affairs, Endo International plc
Performance and results oriented strategic professional who practiced as a hospitalist, along with 15+ years of diverse experience, including US & Global pharmaceutical industry experience in direct and matrix organizations with knowledge and expertise in all functions within Global... Read More →


Tuesday September 14, 2021 1:00pm - 1:15pm EDT

1:15pm EDT

When to collaborate?
  • Delve into a team’s decision-making process when choosing an investigator-initiated study  
  • Weigh the benefits of taking on a smaller investigator study over a larger one based on company needs
  • Examine the process of fine-tuning research concepts


Speakers
avatar for Eric Shen

Eric Shen

Senior Scientist, Global Medical Affairs, United Therapeutics Corporation
Eric Shen is a Senior Scientist at United Therapeutics corporation. He has been working in pharmaceuticals, biotechnology, and research for 15 years and is passionate about generating and communicating scientific evidence in rare diseases. Eric graduated from Cornell University with... Read More →


Tuesday September 14, 2021 1:15pm - 1:45pm EDT

1:15pm EDT

Instilling Disease Awareness/Engagement in your Team
Speakers
avatar for Harmony P. Garges, MD, MPH

Harmony P. Garges, MD, MPH

Senior Vice President, Chief Medical Officer, ViiV Healthcare
Dr. Harmony P. Garges is the Chief Medical Officer at Viiv Healthcare, the only pharmaceutical company dedicated to HIV, and leads the Global Medical team. She is a physician with expertise in paediatric infectious diseases and spent nearly 20 years taking care of children living... Read More →


Tuesday September 14, 2021 1:15pm - 1:45pm EDT

1:15pm EDT

Building a MSL Team: Re-Strategize and Re-think How to Right-Size a MSL Team
Speakers
avatar for Steven Stein, MD

Steven Stein, MD

Sr. Director, Global Field Medical Head, Arena Pharmaceuticals
Steven Stein started his career in the pharmaceutical industry at Takeda in 2004 where he was the Medical Science Liaison for their diabetes franchise.  As an MSL, he also supported the following therapeutic areas: hyperlipidemia, hypertension, obesity and depression.  After being... Read More →


Tuesday September 14, 2021 1:15pm - 1:45pm EDT

1:45pm EDT

Leveraging internal collaboration for mid-sized IST programs
  • Engaging with the Medical Science Liaisons (MSLs) to support scientific discussions and thought leader engagement 
  • Capitalizing on the therapeutic expertise of Medical Directors 
  • Overcoming limited resources by utilizing a rotation program (e.g. clinical operations) 



Speakers
avatar for Kathleen Long

Kathleen Long

Director Medical Affairs, Alkermes
Kathleen Long, MS has spent the past 15 years in various medical affairs, clinical operations and cooperative group roles. She is currently Director for Medical Affairs Operations at Alkermes, Inc. In this role, Kat heads external research programs across Alkermes’ portfolio of... Read More →
avatar for Stephanie Daub (Ebner), Ph.D

Stephanie Daub (Ebner), Ph.D

Director, Field Medical Excellence - Schizophrenia, Alkermes
Stephanie Daub, PhD has spent the past 5.5 years in various medical affairs roles. She is currently a Director of Field Medical Excellence at Alkermes, Inc. In this role, Stephanie is involved in medical strategy and continuing education for Alkermes’ team of medical science liaisons... Read More →


Tuesday September 14, 2021 1:45pm - 2:15pm EDT

1:45pm EDT

Optimizing Medical Affairs Capabilities
  • Identify gaps within your MA organization at all phases of development
  • How to use experts to resource or augment your team
  • Enhance collection and communication of insights from all possible sources of information

Speakers
avatar for Melissa Olivadoti, PhD, CMPP

Melissa Olivadoti, PhD, CMPP

Consultant, Scientific Commercialization LLC
Melissa Olivadoti, PhD, CMPP is a consultant with Scientific Commercialization, a subsidiary of The CM Group.  Melissa holds a PhD in Neuroscience from the University of Michigan and a Certification in Medical Publications Planning from the International Society for Medical Publications... Read More →


Tuesday September 14, 2021 1:45pm - 2:15pm EDT

1:45pm EDT

Your Career: Drive or Be Driven. A Discussion on Professional Development & Strategic Career Planning
  • Self-Awareness –your true strengths/talents, skill/knowledge gaps, weaknesses, likes, dislikes
  • Your Why passion + purpose
  • Individual Development Planning – not just a check the box activity

Speakers
avatar for Elaine Nadeau, PharmD

Elaine Nadeau, PharmD

Director, Leadership Excellence & Field Development, EMD Serono
Elaine Nadeau is an experienced and enthusiastic Medical Affairs professional who has worked in the pharmaceutical industry for over a decade. She has held various roles within Field-Based Medicine, including Sr. Medical Science Liaison (MSL), MSL Training Lead, MSL Manager, and Field... Read More →


Tuesday September 14, 2021 1:45pm - 2:15pm EDT

2:15pm EDT

Panel: Implementing an Industry Standard for IIT Contracts
  • Identify common deliverables required from sponsors
  • Explore how the industry can come together to set standard guidelines to accelerate contracting timelines
  • Connect with research organizations to gauge areas in which need more focus

Moderators
avatar for Steven Zhang, MD

Steven Zhang, MD

Senior Vice President, Kala Pharmaceuticals

Speakers
avatar for Ramin Farhood

Ramin Farhood

Vice President, Head of Global Medical Affairs, Former AveXis
Dr. Farhood is a pharmacologist, an inspirational Medical Executive and entrepreneur with over 20 years in developing business-aligned and patient-centric medical strategies, tactical plan, and operational excellence with strong commitment to achieving corporate goals while maintaining... Read More →


Tuesday September 14, 2021 2:15pm - 3:00pm EDT

2:15pm EDT

Panel: Discuss Optimal Information Exchange: By When and How? A Multi-Stakeholder Discussion



Moderators
avatar for Deborah Braccia, PhD, MPA

Deborah Braccia, PhD, MPA

Head of Global Medical Affairs Excellence, Kyowa Kirin
Dr. Braccia is a results-driven senior healthcare and biopharmaceutical leader with over 20 years of progressive experience and successes in pharmaceutical, biotech, clinical and academic settings. She is currently the Head of Global Medical Affairs Excellence at Kyowa Kirin. Extensive... Read More →

Speakers
avatar for Sejal Bhagat, PharmD

Sejal Bhagat, PharmD

Regional Director, MSLs, Deciphera Pharmaceuticals
Sejal has 14 years of experience working in various areas of Medical Affairs in the Hematology/Oncology therapeutic area. She graduated from Rutgers University with a Doctor of Pharmacy degree and completed a 1-year residency at Roche Laboratories before joining industry. She has... Read More →
avatar for Ina Shah, PharmD, BCMAS

Ina Shah, PharmD, BCMAS

Executive Director Medical Information, AbbVie
Ina Shah is currently the Executive Director, Global Medical Information at AbbVie. In this role, she is leading a global team that develop medical content and supports medical inquiries from customers. Prior to this, she has held various positions at Hoffmann LaRoche in clinical... Read More →
avatar for Nami Pandit, PharmD, R.Ph

Nami Pandit, PharmD, R.Ph

Senior Director, Global Medical Affairs, Sanofi
Nami Pandit-Abid has 10+ years in Industry working across Pharma, Consulting, and Pharmacy. She currently works at Sanofi Genzyme and is responsible for new indication planning, Medical Education, Publications, Advisory Boards, KOL engagement, and cross functional synergies. Throughout... Read More →


Tuesday September 14, 2021 2:15pm - 3:00pm EDT

2:15pm EDT

Panel: Define the New Role of the MSL / Reshaping the Role of MSLs
  • Impact of COVID on ways of working
  • Engaging virtually
  • Developing New relationships primarily in a virtual world
  • Transitioning back to in-person engagements
  • Is the MSL role just insight gathering?  If so, what constitutes an insight?

Moderators
avatar for Anne M VanBuskirk, MBA, PhD

Anne M VanBuskirk, MBA, PhD

Associate Director Medical Affairs, Takeda Oncology
Anne Van Buskirk PhD, MBA is an Executive MSL / Assoc. Director in US Medical Affairs- Oncology at Takeda Pharmaceuticals. She received her PhD in Immunology and Medical Microbiology from University of Missouri and her MBA with a concentration in ethical leadership from Marist College... Read More →

Speakers
avatar for Ravi Tayi, MD, MPH

Ravi Tayi, MD, MPH

Chief Medical Officer & Head of Global Medical Affairs, Endo International plc
Performance and results oriented strategic professional who practiced as a hospitalist, along with 15+ years of diverse experience, including US & Global pharmaceutical industry experience in direct and matrix organizations with knowledge and expertise in all functions within Global... Read More →
avatar for Jaclyn Quilantan,

Jaclyn Quilantan,

Medical Science Liaison, Kala Pharmaceuticals
Jaclyn is a Medical Science Liaison at Kala Pharmaceuticals. She completed her B.S. in Biology from St. Mary’s University in San Antonio, and her Ph.D. in Biomedical Sciences from the University of North Texas Health Science Center in Fort Worth. After completing her Ph.D. she assumed... Read More →
avatar for Vanessa Johnson

Vanessa Johnson

Senior Director, MSL Excellence, Bayer
Vanessa Johnson is the Senior Director, Global MSL Excellence at Bayer Pharmaceuticals. Vanessa has been active in the industry for over 17 years holding positions of increasing responsibility across Medical Affairs, Marketing and Sales functions. She has extensive experience developing... Read More →
avatar for Keely Dahl, PharmD, RPh

Keely Dahl, PharmD, RPh

Senior Medical Science Liaison, Aurinia Pharmaceuticals Inc.
Keely Dahl, PharmD is a Senior Medical Science Liaison (MSL) who aspires to enhance collaboration across healthcare community for the betterment of people’s health and prosperity. She has been a Medical Affairs professional since 2016 and is a proud employee of Aurinia Pharmaceuticals... Read More →


Tuesday September 14, 2021 2:15pm - 3:00pm EDT

3:00pm EDT

Networking Break
Tuesday September 14, 2021 3:00pm - 3:30pm EDT

3:30pm EDT

Benefits of Incorporating Collaborative Study Models into Your Portfolio
  • How collaborative models can better meet the needs of a product in earlier life cycle stages
  • Have an active role in a study’s protocol design to ensure it meets company standards
  • Creating an open dialogue with the sponsoring organization during data interpretation and publication ensuring successful equal ownership

Speakers
avatar for Swati Pradhan-Bhatt, Ph.D.

Swati Pradhan-Bhatt, Ph.D.

Director, Scientific Affairs, Mallinckrodt Pharmaceuticals
Swati Pradhan-Bhatt, Ph.D. is a medical affairs professional with 5 years of pharmaceutical industry experience and 10+ years of experience in academia.  She currently leads the Scientific Affairs function, which includes a team that supports Investigator-Initiated Research Studies... Read More →


Tuesday September 14, 2021 3:30pm - 4:00pm EDT

3:30pm EDT

The Digital Transformation Journey of Medical Affairs
Speakers
avatar for Barry Lubarsky, PhD

Barry Lubarsky, PhD

Vice President, Medical Affairs Strategy, Alkermes
Barry Lubarsky, PhD, has spent more than 15 years in various medical affairs roles. He is currently Vice President of Medical Affairs Strategy at Alkermes. In this role, Barry leads the medical affairs medical director teams that drive the medical strategic plans in support of Alkermes... Read More →


Tuesday September 14, 2021 3:30pm - 4:00pm EDT

3:30pm EDT

MSL Rules of Engagement: Outlining best practices for your cross functional field teams
  • Provide a framework for establishing ways of working between MSLs and Commercial Field Teams
  • Define best practices when working together in the field and fielding requests for MSLs
  • Review of compliant ways to navigate common scenarios (e.g. Introductions, Medical Presentations, Clinical Trial Discussions, etc)

Speakers
avatar for Maria Urso, PhD

Maria Urso, PhD

Director, Medical Affairs Field Team, Exact Sciences
Maria has worked in Medical Affairs for over a decade. She has held roles as an MSL, MSL Manager, Director of Clinical Research, Director Medical Affairs and is currently the Director of the Medical Affairs Field Team with Exact Sciences. In those roles, she has had the opportunity... Read More →


Tuesday September 14, 2021 3:30pm - 4:00pm EDT

4:00pm EDT

What internal resources are needed to execute external research
  • Key learnings setting up a new IIT program 
  •  Impact on resource demand 
  •  Setting up your internal resources for success (MSLs, IIT coordinators, internal scientist/physicians, budgets, contracts, product delivery, and more) 

Speakers
avatar for Jeremy Keeton

Jeremy Keeton

Advisor ONC IIT,  Eli Lilly and Company
Jeremy Keeton has a degree from Indiana University in Biology and Chemistry, and a Masters in Organic Chemistry from Purdue University.  Jeremy has held several roles at Eli Lilly since 2002: chemist, project manager, clinical project manager, US site selection, and international... Read More →


Tuesday September 14, 2021 4:00pm - 4:30pm EDT

4:00pm EDT

Leveraging Scientific Activity Insights to Inform Medical Strategies
As the industry continues to rethink the profile of medical affairs, it must seek out new competencies, technology solutions, and data sources that better support patient-centric outcomes. Medical affairs leaders are at the forefront of this evolution and newly positioned to rewrite the traditional corporate formula for success. Understanding and analyzing the scientific share of voice of competitive compounds has become increasingly critical when evolving commercialization strategies. These highly specific insights create a foundation for continuous improvements and opportunities to act with greater focus. These efforts allow teams to accurately benchmark external relations and inform strategic engagement.
As innovation increases the complexity of care and the scientific demand of the treating community grows the ability to identify and engage community leaders using insights from medical claims data is now critical for long-term success.

Speakers
avatar for Robert Groebel

Robert Groebel

VP of Global Medical Strategy, Monocl
Robert Groebel is the VP of Global Medical Strategy at Monocl. He is recognized for his ability to create a strategic vision and accelerate innovation via technology. Most recently, he was the Global Vice President, Medical & Account Management Strategy at Veeva Systems. He has more... Read More →


Tuesday September 14, 2021 4:00pm - 4:30pm EDT

4:00pm EDT

Medical Affairs and Digital: Moving from Observers to Active Participants
  • The Acceleration of KOL Online Scientific Dialog
  • Monitoring Online Activity of KOLS & Discovering DOLS
  • DOL and Online Medical Engagement

Speakers
avatar for Melanie Fulton

Melanie Fulton

Sr. Director, Medical Strategy and Operations, Global Medical Affairs, Arena Pharmaceuticals
Melanie Fulton has more than 25 years of multifaceted pharmaceutical experience working across multiple therapeutic areas within the industry including Eli Lilly, Sandoz, Boehringer Ingelheim, and Sanofi. She is currently the Head of Medical Strategy and Operations within Global Medical... Read More →
avatar for Scott Thompson

Scott Thompson

Co-Chief Executive Officer, Acceleration Point
Scott Thompson has been helping medical affairs teams engage differently, generate insights, and improve operations for over 10 years. Scott and the team from Acceleration Point provide consulting, operational support & staffing, and technology solutions specifically designed for... Read More →


Tuesday September 14, 2021 4:00pm - 4:30pm EDT

4:30pm EDT

Panel: How Providing Additional Support to a Study’s Principal Investigator Can Lead to Easier Workflow Processes Throughout its Lifecycle
  • Understand the importance of properly training a PI in IIT overseeing operations
  • Ensure the research team is knowledgeable in protocol writing to avoid issues with submissions
  • Creating a plan for protocol implementation to maintain quality and ensure results

Moderators
avatar for Bryan Bischel

Bryan Bischel

Medical Director, Hepatology, Mallinckrodt Pharmaceuticals
Bryan Bischel is an accomplished senior Medical Affairs professional with more than 20 years of progressively responsible medical affairs experience.  He is a strategic thinker skilled at developing and implementing programs to support medical affairs and corporate level objectives... Read More →

Speakers
avatar for Annette N. Chavez, Pharm.D., BCPS

Annette N. Chavez, Pharm.D., BCPS

Sr. Director, LLT Lead – Dermatology, Arena Pharmaceuticals
Annette Chavez is currently the Senior Medical Director, and Global Medical Lead for Dermatology within Global Medical Affairs Department at Arena Pharmaceuticals. She has more than 10 years of experience in Medical Affairs across many therapeutic areas including nephrology, cardiometabolics... Read More →
avatar for Emilie Jade Misajon

Emilie Jade Misajon

Senior Global Trial Manager, Novartis
Emilie Jade Misajon, MSN, RN, CCRP is a Senior Global Trial Manager at Novartis with over thirteen years of experience in clinical research. She specializes in global trial management, creating and establishing novel programs, as well as training and managing research personnel to... Read More →
avatar for Ravi Tayi, MD, MPH

Ravi Tayi, MD, MPH

Chief Medical Officer & Head of Global Medical Affairs, Endo International plc
Performance and results oriented strategic professional who practiced as a hospitalist, along with 15+ years of diverse experience, including US & Global pharmaceutical industry experience in direct and matrix organizations with knowledge and expertise in all functions within Global... Read More →


Tuesday September 14, 2021 4:30pm - 5:15pm EDT

4:30pm EDT

Panel: Being Strategic in Writing a Medical Plan
  • Understand the value of having a strategic Medical plan
  • Identify critical success factors and potential pitfalls in developing a medical plan that is impactful and complementary to cross-functional team plans

Moderators
avatar for Eva Gallagher, PhD, RN, ANP-BC

Eva Gallagher, PhD, RN, ANP-BC

Vice President, Head of Medical Affairs, Agios Pharmaceuticals
Currently serving as Vice President, Head of Global Medical Affairs at Agios Pharmaceuticals, Eva reports to the Chief Medical Officer. In this role she is responsible for oversight of Scientific Communications, Publications, Medical Information, Health Economics Outcomes Research... Read More →

Speakers
avatar for Susan Malecha

Susan Malecha

Senior Director, Medical Affairs, Puma Biotechnology, Inc.
Susan Malecha is a results-driven versatile medical professional with a proven track record for achievement in the pharmaceutical/biotechnology industry. An accomplished author, she has lectured extensively and is called upon to present the latest developments in the areas of medical... Read More →
avatar for Melanie Fulton

Melanie Fulton

Sr. Director, Medical Strategy and Operations, Global Medical Affairs, Arena Pharmaceuticals
Melanie Fulton has more than 25 years of multifaceted pharmaceutical experience working across multiple therapeutic areas within the industry including Eli Lilly, Sandoz, Boehringer Ingelheim, and Sanofi. She is currently the Head of Medical Strategy and Operations within Global Medical... Read More →
avatar for Debra Sierka

Debra Sierka

Head of Dermatology, US Medical Affairs, Sanofi Genzyme
Debra Sierka is an experienced leader in Medical Affairs with an extensive track record of success developing and leading medical strategy across multiple disciplines and organizations resulting in impactful medical and commercial outcomes.  With over 15 years of clinical experience... Read More →


Tuesday September 14, 2021 4:30pm - 5:15pm EDT

4:30pm EDT

Panel: Benchmarking Performance Metrics in a Hybrid Environment
Moderators
avatar for Susan Giacalone, MSN, MSL-BC, BCMAS

Susan Giacalone, MSN, MSL-BC, BCMAS

National Director, Field Medical Affairs, MacroGenics/ Eversana
Susan Giacalone, MSN, BCMAS, MSL-BC, National Director, Field Medical MacroGenics/ EversanaSusan leads the field medical affairs group for the integrated partnership of EVERSANA and MacroGenics. As a leader in the life sciences industry, she brings more than 20 years of medical affairs... Read More →

Speakers
avatar for Jaclyn Quilantan,

Jaclyn Quilantan,

Medical Science Liaison, Kala Pharmaceuticals
Jaclyn is a Medical Science Liaison at Kala Pharmaceuticals. She completed her B.S. in Biology from St. Mary’s University in San Antonio, and her Ph.D. in Biomedical Sciences from the University of North Texas Health Science Center in Fort Worth. After completing her Ph.D. she assumed... Read More →
avatar for Sheila Komara

Sheila Komara

Former Senior Medical Science Liaison, Mallinckrodt
Medical Science Liaison (MSL) for 20 years in management and staff roles. Expertise includes Hepatology, Sedation, Delirium, and Pain Management, all with a critical care focus.  Launched several drugs and worked with late stage drugs, which has provided experience across the life... Read More →


Tuesday September 14, 2021 4:30pm - 5:15pm EDT

5:15pm EDT

Investigator-Initiated Trials Track Chair - Closing Remarks
Speakers
avatar for Bryan Bischel

Bryan Bischel

Medical Director, Hepatology, Mallinckrodt Pharmaceuticals
Bryan Bischel is an accomplished senior Medical Affairs professional with more than 20 years of progressively responsible medical affairs experience.  He is a strategic thinker skilled at developing and implementing programs to support medical affairs and corporate level objectives... Read More →


Tuesday September 14, 2021 5:15pm - 5:30pm EDT

5:15pm EDT

Medical Affairs Strategy Track Chair - Closing Remarks
Speakers
avatar for Mark Wildgust, PhD

Mark Wildgust, PhD

Vice President, Global Medical Affairs Oncology, Janssen Pharmaceutical Companies of Johnson & Johnson
Mark Wildgust has spent more than 20 years in the pharmaceutical industry working primarily in oncology, hematology and virology. He completed his undergraduate degree in Biological Sciences at the University of Plymouth, UK, and his PhD in Trace Metal Toxicology at the University... Read More →


Tuesday September 14, 2021 5:15pm - 5:30pm EDT

5:15pm EDT

MSL Best Practices Track Chair - Closing Remarks
Speakers
avatar for Ravi Tayi, MD, MPH

Ravi Tayi, MD, MPH

Chief Medical Officer & Head of Global Medical Affairs, Endo International plc
Performance and results oriented strategic professional who practiced as a hospitalist, along with 15+ years of diverse experience, including US & Global pharmaceutical industry experience in direct and matrix organizations with knowledge and expertise in all functions within Global... Read More →


Tuesday September 14, 2021 5:15pm - 5:30pm EDT

5:30pm EDT

Cocktail Networking Reception
Tuesday September 14, 2021 5:30pm - 6:30pm EDT

6:30pm EDT

Conference Day One Concludes
Tuesday September 14, 2021 6:30pm - 6:30pm EDT
 
Wednesday, September 15
 

8:00am EDT

Breakfast
Wednesday September 15, 2021 8:00am - 8:45am EDT

8:45am EDT

Chairperson’s Opening Remarks
Speakers
avatar for Mandeep Kaur, MD, MS

Mandeep Kaur, MD, MS

Vice President and Global Head of Medical, Arena Pharmaceuticals, Inc
Mandeep Kaur is a physician scientist and currently the Vice President, Head of Global Medical at Arena Pharmaceuticals. An experienced leader with over 15 years of research and development experience in both drug and device development. She also has extensive experience in clinical... Read More →


Wednesday September 15, 2021 8:45am - 9:00am EDT

9:00am EDT

Keynote: Fit for Purpose Launch
Speakers
avatar for Kirk Shepard, MD

Kirk Shepard, MD

Chief Medical Officer & SVP, Head of Global Medical Affairs OBG, Eisai, Inc.
Dr. Kirk Shepard is a board-certified medical oncologist and hematologist physician. He is currently CMO and Senior Vice President, Head of Global Medical Affairs Oncology at Eisai Inc. Pharmaceutical Company. Dr. Shepard’s experience in multiple therapeutic areas includes diverse... Read More →


Wednesday September 15, 2021 9:00am - 9:45am EDT

9:30am EDT

Why You Should Pay Attention to Where HCPs Are Interacting Online
  • Understand how online clinician communities (like Doximity and Sermo) are changing the nature of medical consensus and what that means for you
  • Identify how to incorporate these communities and the platforms that foster them, into your engagement and communication strategy

Speakers
avatar for Solomon Banjo

Solomon Banjo

Managing Director, Health Care Ecosystem Research & Product Strategy, Advisory Board
Solomon is a Managing Director with the Advisory Board's life sciences team overseeing the team focused on real-world evidence, value generation, and evidence strategy. In this role, he oversees the research and program strategy as well as the convening of events focused on the intersection... Read More →


Wednesday September 15, 2021 9:30am - 10:00am EDT

10:00am EDT

Networking Break
Wednesday September 15, 2021 10:00am - 10:30am EDT

10:30am EDT

Going Beyond the Therapy with AI: A More Comprehensive Paradigm for Medical Affairs
  • Understand how the medical affairs function is evolving with digital capabilities to meet the needs of healthcare providers and their patients
  • Review actionable, innovative, and data-driven tactics to enhance the value proposition of medical affairs
  • Learn how to leverage AI/ML to extract insights and measure the impact of engagement with providers

Speakers
avatar for Andrew Rosen, PhD

Andrew Rosen, PhD

Director of Global Data Generation, Ionis Pharmaceuticals, Inc.
Andrew Rosen is a Medical Affairs leader supporting gene silencing therapies for patients with rare and severe diseases. Andrew is synergizing his experience in Field Medical Affairs, artificial intelligence, and signal processing to advance new strategies that bring value to clinicians... Read More →


Wednesday September 15, 2021 10:30am - 11:00am EDT

11:00am EDT

Panel: Explore Different Operating Models for Medical Affairs Groups and Discuss How an Organizational Structure Can Impact the Effectiveness of Your Activities
  • Describe examples of different operating models in Medical Affairs organizations, and how factors such as company structure, geography, therapeutic area, or other elements contribute to choices made around operating models
  • Present specific examples of fit-for-purpose structuring or restructuring of Medical Affairs organizations to meet company and business needs
  • Discuss how Medical Affairs leaders socialize new ideas around operating models and measure the effectiveness of different structures

Moderators
avatar for Mandeep Kaur, MD, MS

Mandeep Kaur, MD, MS

Vice President and Global Head of Medical, Arena Pharmaceuticals, Inc
Mandeep Kaur is a physician scientist and currently the Vice President, Head of Global Medical at Arena Pharmaceuticals. An experienced leader with over 15 years of research and development experience in both drug and device development. She also has extensive experience in clinical... Read More →

Speakers
avatar for Ramin Farhood

Ramin Farhood

Vice President, Head of Global Medical Affairs, Former AveXis
Dr. Farhood is a pharmacologist, an inspirational Medical Executive and entrepreneur with over 20 years in developing business-aligned and patient-centric medical strategies, tactical plan, and operational excellence with strong commitment to achieving corporate goals while maintaining... Read More →
avatar for Heather Abourjaily, PharmD

Heather Abourjaily, PharmD

Head - Global Scientific Communications, Vertex Pharmaceuticals
Dr. Abourjaily is an experienced Scientific Communications leader with over 15 years of progressively increasing responsibilities in the biopharmaceutical industry.  Her global scientific communication roles have encompassed Strategic Scientific Communications, Publications, Medical... Read More →
avatar for Pannie Trifillis, PhD

Pannie Trifillis, PhD

VP and Head of Global Scientific Affairs, Global Medical Affairs, PTC Therapeutics, Inc.
Dr. Pannie Trifillis is Vice President and Head of Global Scientific Affairs, overseeing PTC Therapeutics’ functions in Medical Communications, Publications, Medical Information and Medical Education & Training. In 1999, she joined PTC as the first employee and scientist and has... Read More →


Wednesday September 15, 2021 11:00am - 11:45am EDT

11:45am EDT

Conference Chair Introduces Tracks
Speakers
avatar for Mandeep Kaur, MD, MS

Mandeep Kaur, MD, MS

Vice President and Global Head of Medical, Arena Pharmaceuticals, Inc
Mandeep Kaur is a physician scientist and currently the Vice President, Head of Global Medical at Arena Pharmaceuticals. An experienced leader with over 15 years of research and development experience in both drug and device development. She also has extensive experience in clinical... Read More →


Wednesday September 15, 2021 11:45am - 12:00pm EDT

12:00pm EDT

Networking Luncheon
Wednesday September 15, 2021 12:00pm - 1:00pm EDT

1:00pm EDT

Avoidable Pitfalls When Supporting Investigator Initiated Studies
  • Learn from someone who has made most if not all of them
  • 2 “Disaster” case stories
  • Setting up for success (as far as you can) - what is in your control.

Speakers
avatar for Peter Shaw

Peter Shaw

Vice President, Medical Affairs & Chief Medical Officer, Bioventus
Peter Shaw is Global Vice President of Medical Affairs and Chief Medical Officer at Bioventus having spent the previous three years as Senior Medical Director in Medical Affairs at Ferring Pharmaceuticals where he was responsible for all US Orthopaedic and Specialty Products. Prior... Read More →


Wednesday September 15, 2021 1:00pm - 1:30pm EDT

1:00pm EDT

Best Practices for Approaches for Launch Planning for Evidence Generation in Oncology
  • Learn how to think strategically about evidence generation planning to support a successful evidence plan
  • Break apart how you should consider unmet need and clinical/value story in evidence generation planning
  • Essential elements and steps towards creating a successful and effective evidence plan
  • Learn best practice approaches in turning evidence into an actionable launch plan to communicate your clinical and value story

Speakers
avatar for Mark Wildgust, PhD

Mark Wildgust, PhD

Vice President, Global Medical Affairs Oncology, Janssen Pharmaceutical Companies of Johnson & Johnson
Mark Wildgust has spent more than 20 years in the pharmaceutical industry working primarily in oncology, hematology and virology. He completed his undergraduate degree in Biological Sciences at the University of Plymouth, UK, and his PhD in Trace Metal Toxicology at the University... Read More →


Wednesday September 15, 2021 1:00pm - 1:30pm EDT

1:00pm EDT

MSLs and Diversity in Engagement
  • Navigating the many Types of diversity
  • Diversity and  “rules of engagement”  for virtual and in-person meetings

Speakers
avatar for Anne M VanBuskirk, MBA, PhD

Anne M VanBuskirk, MBA, PhD

Associate Director Medical Affairs, Takeda Oncology
Anne Van Buskirk PhD, MBA is an Executive MSL / Assoc. Director in US Medical Affairs- Oncology at Takeda Pharmaceuticals. She received her PhD in Immunology and Medical Microbiology from University of Missouri and her MBA with a concentration in ethical leadership from Marist College... Read More →


Wednesday September 15, 2021 1:00pm - 1:30pm EDT

1:30pm EDT

How Mid-Sized Pharma Can Utilize Technology to Optimize IIT Management
  • Shift from manual operations to an automated system to streamline daily functions  
  • Understand how digital processes can permit teams to take on larger number of studies, while also maintaining quality  
  • Adapting best practices used in big pharma in large portfolio management

Speakers
avatar for Temire Bob-Egbe

Temire Bob-Egbe

Senior Manager, Global IST Operations, Jazz Pharmaceuticals


Wednesday September 15, 2021 1:30pm - 2:00pm EDT

1:30pm EDT

Digital is here to Stay: Awareness, Education, and Scientific Engagement
  • Discuss digital transformation journey from traditional medical affairs to digital medical affairs
  • Learn objectives for digital advisors
  • Amplify publications and medical communication via digital strategy

Speakers
avatar for Elizabeth Pash PhD(c), MS, RD, LDN

Elizabeth Pash PhD(c), MS, RD, LDN

Vice President, Medical Affairs, Gelesis
Elizabeth is a registered and licensed dietitian with 20 years of clinical nutrition experience.  She plays a critical role in shaping and executing the overall medical strategic plan and key operational decisions for Gelesis. Before joining Gelesis, she was Head of Medical Science... Read More →


Wednesday September 15, 2021 1:30pm - 2:00pm EDT

1:30pm EDT

A Data-Driven Approach for Evolving MSL Teams
  • Industry-wide trends in the evolution of the MSL role
  • Managing change for evolving MSL teams
  • Using data to enhance strategy for the new MSL role
  • Distilling millions of data points available to key elements the new MSL needs to perform best

Speakers
avatar for Molly Upton

Molly Upton

Global Key Account Manager, H1
Molly has spent her career helping clients achieve their goals. As Global Key Account Manager for H1, she aids the life sciences industry with dynamic data and solutions to enable smarter, better, faster decisions.Molly holds a Bachelor of Arts from New York University and a Master... Read More →
avatar for Nayanica Banerjee

Nayanica Banerjee

Manager, Client Solutions/ Strategy, H1 Insights
Nayanica is a global life sciences consultant/ SME (subject matter expert) with a unique, cross-functional background in biotechnology engineering, pharmaceutical compliance and medical strategy. In her current role at H1, she works closely with key players in the industry to support... Read More →


Wednesday September 15, 2021 1:30pm - 2:00pm EDT

2:00pm EDT

Panel: Explore Best Practices for Managing IITs within Small to Medium Sized Pharma
  • Monitor IITs with a limited pool of resources
  • Manage time appropriately to complete all functions and deliverables necessary for a study
  • Promote open communication with investigators to avoid complications and ensure positive outcomes

Moderators
avatar for Peter Shaw

Peter Shaw

Vice President, Medical Affairs & Chief Medical Officer, Bioventus
Peter Shaw is Global Vice President of Medical Affairs and Chief Medical Officer at Bioventus having spent the previous three years as Senior Medical Director in Medical Affairs at Ferring Pharmaceuticals where he was responsible for all US Orthopaedic and Specialty Products. Prior... Read More →

Speakers
avatar for Kate Josephs

Kate Josephs

Director, ISR Operations| Medical Affairs, Mirati Therapeutics, Inc.
Kate is the Director of ISR/NRDG Operations within Medical Affairs at Mirati Therapeutics.  Kate spent 4 years at TESARO as the strategic and operational lead for the ISR/Collaborative Study program across multiple solid tumor indications for early and late-stage Immunotherapy assets... Read More →
avatar for Scott McConnell, PharmD

Scott McConnell, PharmD

Vice President Medical Affairs, Chiasma
Scott graduated with a Pharm.D. from Creighton University. He then completed a one-year Pharmacotherapy Residency and a two-year Infectious Diseases Fellowship. He served on faculty at both the University of Arkansas and Creighton University Pharmacy Schools, teaching infectious diseases... Read More →
avatar for Kim Reed

Kim Reed

Senior Medical Director, Clinical Sciences, Ophthalmology, Regeneron Pharmaceuticals
Kim currently holds the position of Senior Medical Director in Ophthalmology at Regeneron Pharmaceuticals, where she is leading clinical development activities in wet AMD and Diabetic Macular Edema.  Previously, Kim was a Medical Director in Medical Affairs at Regeneron and a Shire... Read More →


Wednesday September 15, 2021 2:00pm - 2:45pm EDT

2:00pm EDT

Panel: Building Medical Affairs Capabilities for the First Time
Moderators
avatar for Mark Wildgust, PhD

Mark Wildgust, PhD

Vice President, Global Medical Affairs Oncology, Janssen Pharmaceutical Companies of Johnson & Johnson
Mark Wildgust has spent more than 20 years in the pharmaceutical industry working primarily in oncology, hematology and virology. He completed his undergraduate degree in Biological Sciences at the University of Plymouth, UK, and his PhD in Trace Metal Toxicology at the University... Read More →

Speakers
avatar for Brett Balzer

Brett Balzer

GM, Medical Affairs, Komodo Health
Brett has been responsible for the strategic direction, growth, and customer success of Komodo’s medical affairs practice for the past 8 years. He has collaborated on dozens of implementations across MI contact centers, medical portals, safety solutions, and mobile tools. Brett... Read More →
avatar for Sylvia Hanna, MD

Sylvia Hanna, MD

Vice President, Head of Medical Affairs, Avalo Therapeutics
Cornell-trained OB/GYN and medical executive with over 16 years of diverse industry experience across several therapeutic areas in pharmaceuticals and medical devices. Experience includes leading Medical strategy spanning pre-launch, launch and mature life cycle product management... Read More →


Wednesday September 15, 2021 2:00pm - 2:45pm EDT

2:00pm EDT

Panel: How to Gather and Optimally Manage Clinical and Field Insights to Help Shape Your Medical Strategy
The panel will review of methods of:
i. Tracking, monitoring, and acting on insights
ii. Best practices to “connect the dots”, create an actionable insights workflow, and track the lifecycle of insights
iii. Using insights and actions to support business decisions within medical affairs and the broader organization

Moderators
avatar for Maria Urso, PhD

Maria Urso, PhD

Director, Medical Affairs Field Team, Exact Sciences
Maria has worked in Medical Affairs for over a decade. She has held roles as an MSL, MSL Manager, Director of Clinical Research, Director Medical Affairs and is currently the Director of the Medical Affairs Field Team with Exact Sciences. In those roles, she has had the opportunity... Read More →

Speakers
avatar for Andrew Rosen, PhD

Andrew Rosen, PhD

Director of Global Data Generation, Ionis Pharmaceuticals, Inc.
Andrew Rosen is a Medical Affairs leader supporting gene silencing therapies for patients with rare and severe diseases. Andrew is synergizing his experience in Field Medical Affairs, artificial intelligence, and signal processing to advance new strategies that bring value to clinicians... Read More →
avatar for Davida J. White, MD

Davida J. White, MD

Lead, Global Field Medical Excellence and Operations, Organon
Davida J. White, M.D. is a health care leader with administrative and clinical experience in the government, academic, biopharmaceutical and medical device industry settings.  She is currently Head of Global Field Medical Center of Excellence at Organon.  Prior to joining Organon... Read More →
avatar for Brant Jarrett

Brant Jarrett

Executive Director, Head of Field Medical Affairs, Mallinckrodt Pharmaceuticals
Brant Jarrett is the Executive Director of Field Medical Affairs at Mallinckrodt Pharmaceuticals. He entered Pharma as an MSL and has had various leadership positions in Medical Affairs including Regional Director, National Director, Medical Director, and Sr. Director Field Medical... Read More →


Wednesday September 15, 2021 2:00pm - 2:45pm EDT

2:45pm EDT

Investigator-Initiated Trials Track Chair - Closing Remarks
Speakers
avatar for Bryan Bischel

Bryan Bischel

Medical Director, Hepatology, Mallinckrodt Pharmaceuticals
Bryan Bischel is an accomplished senior Medical Affairs professional with more than 20 years of progressively responsible medical affairs experience.  He is a strategic thinker skilled at developing and implementing programs to support medical affairs and corporate level objectives... Read More →


Wednesday September 15, 2021 2:45pm - 3:00pm EDT

2:45pm EDT

Medical Affairs Strategy Track Chair - Closing Remarks
Speakers
avatar for Mark Wildgust, PhD

Mark Wildgust, PhD

Vice President, Global Medical Affairs Oncology, Janssen Pharmaceutical Companies of Johnson & Johnson
Mark Wildgust has spent more than 20 years in the pharmaceutical industry working primarily in oncology, hematology and virology. He completed his undergraduate degree in Biological Sciences at the University of Plymouth, UK, and his PhD in Trace Metal Toxicology at the University... Read More →


Wednesday September 15, 2021 2:45pm - 3:00pm EDT

2:45pm EDT

MSL Best Practices Track Chair - Closing Remarks
Speakers
avatar for Davida J. White, MD

Davida J. White, MD

Lead, Global Field Medical Excellence and Operations, Organon
Davida J. White, M.D. is a health care leader with administrative and clinical experience in the government, academic, biopharmaceutical and medical device industry settings.  She is currently Head of Global Field Medical Center of Excellence at Organon.  Prior to joining Organon... Read More →


Wednesday September 15, 2021 2:45pm - 3:00pm EDT

3:00pm EDT

Conference Concludes
Wednesday September 15, 2021 3:00pm - 3:00pm EDT